These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2452917

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Varró A, Szénási G, Nánási PP.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
    Yamaguchi I, Singh BN, Mandel WJ.
    Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.
    Sunami A, Sawanobori T, Adaniya H, Hiraoka M.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258
    [Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I, El-Reyani NE, Farkas A, Virág L, Iost N, Leprán I, Mátyus P, Varró A, Papp JG.
    Eur J Pharmacol; 2000 Sep 15; 404(1-2):181-90. PubMed ID: 10980278
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle.
    Takanaka C, Sarma JS, Singh BN.
    J Cardiovasc Pharmacol; 1992 Feb 15; 19(2):290-8. PubMed ID: 1376799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.
    Szél T, Koncz I, Jost N, Baczkó I, Husti Z, Virág L, Bussek A, Wettwer E, Ravens U, Papp JG, Varró A.
    Eur J Pharmacol; 2011 Jul 15; 662(1-3):31-9. PubMed ID: 21550338
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
    Baláti B, Iost N, Simon J, Varró A, Papp JG.
    Gen Pharmacol; 2000 Feb 15; 34(2):85-93. PubMed ID: 10974415
    [Abstract] [Full Text] [Related]

  • 15. Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.
    Nakaya Y, Elharrar V, Surawicz B.
    Cardiovasc Drugs Ther; 1987 Aug 15; 1(2):141-53. PubMed ID: 3154317
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
    Weld FM, Bigger JT, Swistel D, Bordiuk J, Lau YH.
    J Pharmacol Exp Ther; 1979 Aug 15; 210(2):222-8. PubMed ID: 458628
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues.
    Steinberg MI, Wiest SA.
    J Cardiovasc Pharmacol; 1984 Aug 15; 6(4):614-21. PubMed ID: 6206315
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects of detajmium on isolated dog cardiac ventricular and Purkinje fibers.
    Hála O, Németh M, Varró A, Papp JG.
    J Cardiovasc Pharmacol; 1994 Oct 15; 24(4):559-65. PubMed ID: 7528838
    [Abstract] [Full Text] [Related]

  • 19. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P, Acsai K, Virág L, Tálosi L, Jost N, Biliczki A, Papp JG, Varró A.
    Eur J Pharmacol; 2005 Mar 14; 510(3):161-6. PubMed ID: 15763239
    [Abstract] [Full Text] [Related]

  • 20. Differential electrophysiologic effects of mexiletine on normal and hypoxic canine Purkinje fibers.
    Burke GH, Berman ND.
    J Cardiovasc Pharmacol; 1985 Mar 14; 7(6):1096-100. PubMed ID: 2418294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.